This significant heterogeneity was partially resolved by leave-one-out of Sun 2024 [ 25 ] due to the highly significant change they produced as the patients had high baseline NIHSS compared with other studies (Supplementary Fig. 6 ).
← all excerpts
Exploring the Efficacy and Safety of Argatroban as an Adjunct to Antiplatelet Therapy in Ischemic Stroke Patients: A Systematic Review and Meta-analysis.
1
—
—